Healthtech Investors & VC Firms in Germany
220 firms in this list, with a median first check of $540K. 66 of them lead rounds. Generated from verified public data and updated continuously.
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
43 people
Korys
HalleSeries A–Late Stage$5.4M
40 people
Seventure Partners
ParisSeed–Growth
7 people
Norrsken VC
StockholmSeed–Growth$1.1M – $3.2M
25 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Verium AG
ZurichGrowth$10M
42 people
M Ventures
Los AngelesSeed–Growth$10.8M
12 people
Nauta Capital
BarcelonaPre-Seed–Series A$1.1M – $5.4M
22 people
Kurma Partners
ParisPre-Seed–Series B$162K – $10.8M
22 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Red River West
Paris, Ile-De-FrancePre-Seed–Late Stage$5.4M – $54M
34 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
26 people
Equistone Partners Europe
LondonGrowth$27M – $216M
4 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
12 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
18 people
Eurazeo
ParisSeed–Late Stage
15 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
25 people
Princeville Capital
San FranciscoSeries A–Late Stage
26 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
21 people
Scale Capital
CopenhagenSeed–Series A$1.1M – $3.3M
19 people
EMZ Partners
Paris$16M – $160M
30 people
Signia Venture Partners
Menlo ParkSeed–Series A$500K – $2M
8 people
LAUNCHub Ventures
SofiaPre-Seed–Series A$324K – $3.2M
11 people
Related lists
Investors & VC Firms in North America (13463)Investors & VC Firms in United States (12509)Investors & VC Firms in Europe (5824)Crypto & Web3 Investors & VC Firms (4943)Investors & VC Firms in Global (4734)AI & Machine Learning Investors & VC Firms (4509)Fintech Investors & VC Firms (4463)SaaS Investors & VC Firms (4201)Healthtech Investors & VC Firms (4103)Enterprise Software Investors & VC Firms (3934)
Data sourced from public filings and firms' own websites — see our methodology.








































































































